HomeNews

News

FDA Evaluations NDA for Dordaviprone in Recurrent H3 K27M-Mutant Diffuse Glioma

Chimerix submitted a brand new drug software to the FDA looking for accelerated approval for dordaviprone to deal with sufferers with recurrent H3...

A Look Again at 2024

Looking again at pancreatic most cancers updates in 2024.This previous yr, we noticed the panorama of pancreatic most cancers analysis and remedy proceed...

AYA Sufferers With Most cancers, ‘In Between’ Children and Adults, Face Distinctive Issues

Adolescent and younger grownup (AYA) sufferers with most cancers, who discover themselves between pediatric and grownup sufferers, usually face issues and points distinctive...

CAR T-Cell Remedy Yescarta Continues to Display Sturdy Responses in Follicular Lymphoma

Therapy with the CAR T-cell remedy Yescarta (axicabtagene ciloleucel) continued to point out deep and sturdy responses, representing a probably healing therapy choice...

Embracing Change within the Face of Growing older and Breast Most cancers

Bonnie Annis is a breast most cancers survivor, recognized in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes....

Hot Topics